Belongs to the therapeutic class of tyrosine kinase inhibitors(TKIs), Specifically a multitargeted TKI.
Generic Name:
Cabozantinib
Indication:
For:
Treating advanced Renal Cell Carcinoma (RCC), Help at cellular carcinoma(HCC), and differentiated Thyroid Cancer (DTC), often after prior treatments and also for certain Neuroendocrine Tumors(NETs).
Supplied as:
Tablet:
20mg (10’s, 20’s,30’s,90’s)
40mg (10’s, 20’s,30’s)
60mg (10’s, 20’s,30’s)
Disclaimer:
Please consult your doctor before taking any medicine. To be sold only on prescription.